Solange Peters
Vermögen: 192 180 $ am 31.07.2026
Vermögen: 192 180 $ am 31.07.2026
Solange Peters is currently Director at Swiss Cancer League since 2017, Independent Director at Galenica AG since 2023, Independent Director at Transgene SA, President of the International Cancer Foundation since 2021, Member of the European Society for Medical Oncology, and Head of the Department of Medical Oncology at Centre Hospitalier Universitaire Vaudois since 2002.
Formerly, Dr. Peters was Professor at the University of Lausanne from 2002 to 2006.
Education includes a doctorate from the University of Lausanne.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2025 | 1’809 ( 0% ) | 192 180 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GALENICA AG | Direktor/Vorstandsmitglied | 11.05.2023 |
| TRANSGENE | Direktor/Vorstandsmitglied | - |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Corporate Officer/Principal | - |
Swiss Cancer League | Direktor/Vorstandsmitglied | 01.01.2017 |
International Cancer Foundation
International Cancer Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Präsident | 01.01.2021 |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Operates university hospitals | Corporate Officer/Principal | 01.01.2002 |
| Unternehmen | Position | Ende |
|---|---|---|
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2006 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Health Services |
Swiss Cancer League | |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Operates university hospitals | Health Services |
Galenica AG
Galenica AG Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals and healthcare products | Distribution Services |
International Cancer Foundation
International Cancer Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen